Drug profile · INN
nedocromil sodium
TILADE
nedocromil sodium (TILADE) is a unknown. Route of administration: ophthalmic. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — nedocromil sodium
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
nedocromil sodium (TILADE) is a unknown. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
INN nedocromil sodium
Brand TILADE
Mechanism Unknown
Route OPHTHALMIC
Formulation AEROSOL, METERED
Mechanism of action
Unknown
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is nedocromil sodium?
nedocromil sodium (TILADE) is a unknown. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for nedocromil sodium?
TILADE is a marketed brand name for nedocromil sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of nedocromil sodium?
nedocromil sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.